Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (191-200 of 403) with videos related to

Pageof 41
Sort By:
Vaccine|October 11, 2023
Reassurance of population immunity to diphtheria in England: Results from a 2021 national serosurveyAmoolya Vusirikala, Simon Tonge, Abigail Bell, et al.
Clinical and Diagnostic Laboratory Immunology|November 13, 2004
Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adultsJo Southern, Sarah Deane, Lindsey Ashton, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccineRay Borrow, Nick Andrews, Helen Findlow, et al.
Vaccine|October 27, 2016
Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal InitiativeRay Borrow, Jin-Soo Lee, Julio A Vázquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidisCariad M Evans, Catherine B Pratt, Mary Matheson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 4, 2025
Impact of molecular point-of-care testing on surveillance and public health management of invasive meningococcal diseaseEmma J Heymer, Stephen A Clark, Helen Campbell, et al.
Sexually Transmitted Infections|December 28, 2020
HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in LondonEleanor M King, David Mesher, Pam Sonnenberg, et al.
The Pediatric Infectious Disease Journal|February 16, 2012
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdomHelen Findlow, Ray Borrow, Nick Andrews, et al.
Journal of Occupational Medicine and Toxicology (London, England)|July 30, 2014
Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccineJamie Findlow, Helen Findlow, Sarah Frankland, et al.
Plos One|January 2, 2025
A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infectionsSoeren Metelmann, Alexander Thompson, Anna Donten, et al.
Pageof 41

Showing results (191-200 of 403) with videos related to

Sort By:
Pageof 41
Vaccine|October 11, 2023
Reassurance of population immunity to diphtheria in England: Results from a 2021 national serosurveyAmoolya Vusirikala, Simon Tonge, Abigail Bell, et al.
Clinical and Diagnostic Laboratory Immunology|November 13, 2004
Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adultsJo Southern, Sarah Deane, Lindsey Ashton, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccineRay Borrow, Nick Andrews, Helen Findlow, et al.
Vaccine|October 27, 2016
Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal InitiativeRay Borrow, Jin-Soo Lee, Julio A Vázquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidisCariad M Evans, Catherine B Pratt, Mary Matheson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 4, 2025
Impact of molecular point-of-care testing on surveillance and public health management of invasive meningococcal diseaseEmma J Heymer, Stephen A Clark, Helen Campbell, et al.
Sexually Transmitted Infections|December 28, 2020
HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in LondonEleanor M King, David Mesher, Pam Sonnenberg, et al.
The Pediatric Infectious Disease Journal|February 16, 2012
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdomHelen Findlow, Ray Borrow, Nick Andrews, et al.
Journal of Occupational Medicine and Toxicology (London, England)|July 30, 2014
Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccineJamie Findlow, Helen Findlow, Sarah Frankland, et al.
Plos One|January 2, 2025
A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infectionsSoeren Metelmann, Alexander Thompson, Anna Donten, et al.
Pageof 41